| Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | 2227 | Peak area | HAHA | TNF-alpha+IL-17A |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | 2641 | Peak area | PAK | Untreated |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | 4107 | Peak area | HAHA | IL-17A |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | 49333 | Peak area | BS4 | TNF-alpha |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | 75456 | Peak area | BS4 | IL-17A |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | Peak area | BS4 | IFN-G | |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | Peak area | BS4 | TNF-alpha+IL-17A | |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | Peak area | BS4 | Untreated | |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | Peak area | HAHA | IFN-G | |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | Peak area | HAHA | TNF-alpha | |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | Peak area | HAHA | Untreated | |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | Peak area | PAK | IFN-G | |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | Peak area | PAK | IL-17A | |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | Peak area | PAK | TNF-alpha | |
| Reversed phase NEGATIVE ION MODE | 3-PHOSPHOGLYCERATE (CAS# ); (M-H)- | Peak area | PAK | TNF-alpha+IL-17A |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|